Jeil Pharm Free Cash Flow Generation Index
Jeil Pharm free cash flow generation index. Jeil Pharm (002620) has a Free Cash Flow Generation Index of -2.85x as of March 2026. Free cash flow of ₩-1.27 Billion represents -3% of operating cash flow (₩447.08 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Jeil Pharm (2011–2025)
Free cash flow generation index of Jeil Pharm from 2011 to 2025. Historical FCF Generation Index trend for Jeil Pharm across 8 annual periods. See 002620 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Jeil Pharm Free Cash Flow Generation Index by Year (2011–2025)
Jeil Pharm free cash flow generation index by year from 2011 to 2025. Year-by-year Free Cash Flow Generation Index for Jeil Pharm. For the full cash flow conversion analysis, see Jeil Pharm (002620) cash conversion ratio.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | -22.90x | ₩-8.94 Billion | ₩390.26 Million | ₩9.33 Billion | ▼ -4382.3% |
| 2024 | -0.51x | ₩-2.32 Billion | ₩4.54 Billion | ₩6.86 Billion | ▲ +33.7% |
| 2021 | -0.77x | ₩-10.33 Billion | ₩13.40 Billion | ₩23.69 Billion | ▼ -182.5% |
| 2019 | 0.93x | ₩23.56 Billion | ₩25.22 Billion | ₩37.69 Billion | ▲ +87.5% |
| 2017 | 0.50x | ₩2.95 Billion | ₩5.92 Billion | ₩2.94 Billion | ▼ -86.4% |
| 2016 | 3.67x | ₩41.68 Billion | ₩11.36 Billion | ₩30.33 Billion | ▲ +6.2% |
| 2015 | 3.46x | ₩9.48 Billion | ₩2.74 Billion | ₩6.74 Billion | ▲ +77.5% |
| 2011 | 1.95x | ₩46.03 Billion | ₩23.63 Billion | ₩22.40 Billion | — |